Revonto
- Product NDC
- 27505-003
- 11-digit product format
- 275050003
- Labeler code
- 27505
- Product ID
- 27505-003_cfcfad0f-e5e4-bfd6-e053-2995a90a0cef
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dantrolene sodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- US WorldMeds, LLC
- Application
- ANDA078378
- Marketing category
- ANDA
- Marketing start
- 2012-06-04
- Marketing end
- 0000-00-00
- Substance
- DANTROLENE SODIUM
- Active strength
- 20 mg/60mL
- Pharmacologic classes
- Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 27505-003-67 | 27505000367 | 6 VIAL, GLASS in 1 CARTON (27505-003-67) > 60 mL in 1 VIAL, GLASS | 2012-06-04 | 0000-00-00 | No | No | Current |